Authors
Loading...
Randomized placebo-controlled trial finds modified citrus pectin does not alter collagen markers in hypertension, indicating Gal-3 inhibition needs alternative targets.
Lau et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: